Please assess the completion status of the following clinical trial:

Trial Title: Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
* INCLUSION CRITERIA:~In order to be eligible to participate in this study, an individual must meet all of the following criteria:~1. Stated willingness to comply with all study procedures and availability for the duration of the study~2. Male or female, aged 18 or older.~3. History of positive PCR or positive IgG for SARS-CoV-2 cases and if known history of COVID-19 infection, at least 30 days passed since a positive PCR for SARS-COV-2 and have been asymptomatic for at least 10 days.~4. Willing to undergo study required testing and blood draw.~5. Willing to have blood samples stored for future research.~EXCLUSION CRITERIA:~An individual who meets any of the following criteria will be excluded from participation in this study:~1. Current symptoms consistent with COVID-19 infection.~2. Any condition or event that, in the PI s opinion, may substantially increase the risk associated with study participation or compromise the study's scientific objectives. Conditions that exclude a subject are considered to be unlikely, but an example would include having an acute respiratory infection or recent exposure that would make it unsafe to perform study procedures or obtain blood samples.~3. Pregnant and decisionally impaired individuals will be excluded from participation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Affected Participants (Type: None): Participants previously diagnosed with COVID-19.

Based on this trial design, predict the completion outcome and termination type (if applicable).